Cargando…

Baseline Subject Characteristics Predictive of Compliance with Study-Mandated Prostate Biopsy in Men at Risk of Prostate Cancer: Results from REDUCE

INTRODUCTION: Study compliance is crucial when the study outcome is determined by an invasive procedure, such as prostate biopsy. To investigate predictors of compliance in study-mandated prostate biopsies, we analyzed demographic, clinical and reported lifestyle data from the REDUCE trial. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, Sean, Sun, Stephanie, Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Vidal, Adriana C., Freedland, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994539/ https://www.ncbi.nlm.nih.gov/pubmed/26926927 http://dx.doi.org/10.1038/pcan.2016.5

Ejemplares similares

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study
por: Jamnagerwalla, Juzar, et al.
Publicado: (2017)

Racial differences in prostate inflammation: results from the REDUCE study
por: Vidal, Adriana C., et al.
Publicado: (2016)

Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study
por: Jenkins, Kimberly R., et al.
Publicado: (2021)

Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)

Lower urinary tract symptoms and their severity in men subjected to prostate biopsy
por: Dobruch, Jakub, et al.
Publicado: (2014)

Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort
por: Freedland, Alexis R., et al.
Publicado: (2021)

Urinary Outcomes for Men With High Baseline International Prostate Symptom Scores Treated With Prostate SBRT
por: Gorovets, Daniel, et al.
Publicado: (2020)

Political beliefs affect compliance with government mandates()
por: Painter, Marcus, et al.
Publicado: (2021)

Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors
por: Tafuri, Alessandro, et al.
Publicado: (2020)

Re: Commentary on “The association between sexual function and prostate cancer risk in US veterans”
por: Vidal, Adriana C, et al.
Publicado: (2018)

The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Prostate-specific antigen-based screening: controversy and guidelines
por: Kim, Eric H, et al.
Publicado: (2015)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
por: Truong, Matthew, et al.
Publicado: (2017)

Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk
por: Xiao, Jialin, et al.
Publicado: (2017)

Does Prostate Volume Correlate with Vitamin D Deficiency Among Men Undergoing Prostate Biopsy?
por: Murphy, Adam B., et al.
Publicado: (2016)

What predicts emotional response in men awaiting prostate biopsy?
por: Groarke, AnnMarie, et al.
Publicado: (2018)

Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019)

Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men
por: Vidal, Adriana C., et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15)
por: Aghdam, Nima, et al.
Publicado: (2020)

The association between sexual function and prostate cancer risk in US veterans
por: Zapata, Daniel F, et al.
Publicado: (2017)

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
por: Roobol, Monique J., et al.
Publicado: (2011)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
por: Kelkar, Sonia, et al.
Publicado: (2021)

Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
por: Manecksha, Rustom P., et al.
Publicado: (2012)

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
por: Grant, Delores J., et al.
Publicado: (2017)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

Prostate Cancer Detection at Rebiopsy After an Initial Benign Diagnosis: Results Using Sextant Extended Prostate Biopsy
por: Leite, Katia Ramos Moreira, et al.
Publicado: (2008)

Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies
por: Sheikh, Nissar, et al.
Publicado: (2016)

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
por: Zhu, Yao, et al.
Publicado: (2015)

Evaluation of an Epithelial Plasticity (EP) Biomarker Panel in Men with Localized Prostate Cancer
por: Armstrong, Andrew J, et al.
Publicado: (2015)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
por: Fiamegos, Alexandros, et al.
Publicado: (2016)

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
por: Willis, Sarah R, et al.
Publicado: (2014)

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients
por: Klaassen, Zachary, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q3qd21s8t07dh9421m9h06h7e3